0001610717-23-000398.txt : 20231212
0001610717-23-000398.hdr.sgml : 20231212
20231212181639
ACCESSION NUMBER: 0001610717-23-000398
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231211
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duncan Jason
CENTRAL INDEX KEY: 0001741553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41802
FILM NUMBER: 231482407
MAIL ADDRESS:
STREET 1: C/O ALBIREO PHARMA, INC.
STREET 2: 10 POST OFFICE SQUARE, SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neumora Therapeutics, Inc.
CENTRAL INDEX KEY: 0001885522
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 844367680
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY, SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (857) 760-0900
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY, SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: RBNC Therapeutics, Inc.
DATE OF NAME CHANGE: 20210929
4
1
form4.xml
X0508
4
2023-12-11
0001885522
Neumora Therapeutics, Inc.
NMRA
0001741553
Duncan Jason
C/O NEUMORA THERAPEUTICS, INC.
490 ARSENAL WAY, SUITE 200
WATERTOWN
MA
02472
true
Chief Legal Officer
false
Stock Option (Right to Buy)
12.97
2023-12-11
4
A
0
400000
0
A
2033-12-10
Common Stock
400000
400000
D
25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
/s/ Joshua Pinto, as Attorney-in-Fact for Jason Duncan
2023-12-12